|
|
||||||||
Journal of Lipid Research, Vol 30, 681-690, Copyright © 1989 by Lipid Research, Inc.
ARTICLES |
EE Largis, CH Wang, VG DeVries and SA Schaffer
American Cyanamid Company, Medical Research Division, Pearl River, NY 10965.
CL 277,082 (I) was found to be a potent inhibitor of acyl CoA:cholesterol acyltransferase (ACAT, EC 2.3.1.26) in microsomes from a variety of tissues with IC50 values of 0.14 microM for intestinal mucosal microsomes, 0.74 microM for liver, and 1.18 microM for rat adrenal. I was also shown to inhibit ACAT in cultured smooth muscle cells (IC50 = 0.8 microM) and was found to be specific in inhibiting cholesterol esterification since it did not inhibit fatty acid incorporation into triglycerides or phospholipids. Also, other cholesterol esterifying enzymes such as lecithin:cholesterol acyltransferase (LCAT) and pancreatic cholesterol esterase were not inhibited by I, nor was esterification of retinol by acyl CoA:retinol acyltransferase (ARAT) from intestinal mucosal microsomes inhibited. I was a potent inhibitor of cholesterol absorption in cholesterol-fed rats by markedly inhibiting increases in liver and serum cholesterol concentration (ED50 = 5.2 mg/kg per day) while increasing the excretion of neutral 14C-labeled sterol in the feces.
This article has been cited by other articles:
![]() |
A. K. Hihi, M.-C. Beauchamp, R. Branicky, A. Desjardins, I. Casanova, M.-P. Guimond, M. Carroll, M. Ethier, I. Kianicka, K. McBride, et al. Evolutionary conservation of drug action on lipoprotein metabolism-related targets J. Lipid Res., January 1, 2008; 49(1): 74 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. M. Delsing, E. H. Offerman, W. van Duyvenvoorde, H. van der Boom, E. C. M. de Wit, M. J. J. Gijbels, A. van der Laarse, J. W. Jukema, L. M. Havekes, and H. M. G. Princen Acyl-CoA:Cholesterol Acyltransferase Inhibitor Avasimibe Reduces Atherosclerosis in Addition to Its Cholesterol-Lowering Effect in ApoE*3-Leiden Mice Circulation, April 3, 2001; 103(13): 1778 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Aragane, K. Fujinami, K. Kojima, and J. Kusunoki ACAT inhibitor F-1394 prevents intimal hyperplasia induced by balloon injury in rabbits J. Lipid Res., April 1, 2001; 42(4): 480 - 488. [Abstract] [Full Text] |
||||
![]() |
P. T. Chan, W. P. Fong, Y. L. Cheung, Y. Huang, W. K. K. Ho, and Z.-Y. Chen Jasmine Green Tea Epicatechins Are Hypolipidemic in Hamsters (Mesocricetus auratus) Fed a High Fat Diet J. Nutr., June 1, 1999; 129(6): 1094 - 1101. [Abstract] [Full Text] |
||||
![]() |
D. Y. Hui Utility and Importance of Gene Knockout Animals For Nutritional and Metabolic Research J. Nutr., November 1, 1998; 128(11): 2052 - 2057. [Full Text] |
||||
![]() |
I. Ishii, N. Yokoyama, M. Yanagimachi, N. Ashikawa, M. Hata, S. Murakami, Y. Asami, N. Morisaki, Y. Saito, S. Ohmori, et al. Stimulation of Cholesterol Release from Rabbit Foam Cells by the Action of a New Inhibitor for Acyl CoA:Cholesterol Acyltransferase (ACAT), HL-004 J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 115 - 121. [Abstract] [Full Text] |
||||
![]() |
I.J. Martins, B.-C. Mortimer, and T.G. Redgrave Effect of the ACAT Inhibitor CL 277,082 on Apolipoprotein B48 Transport in Mesenteric Lymph and on Plasma Clearance of Chylomicrons and Remnants Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 211 - 216. [Abstract] [Full Text] |
||||
![]() |
F. D. Kolodgie, A. S. Katocs Jr, E. E. Largis, S. M. Wrenn, J. F. Cornhill, E. E. Herderick, S. J. Lee, and R. Virmani Hypercholesterolemia in the Rabbit Induced by Feeding Graded Amounts of Low-Level Cholesterol: Methodological Considerations Regarding Individual Variability in Response to Dietary Cholesterol and Development of Lesion Type Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1454 - 1464. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |